ijms-logo

Journal Browser

Journal Browser

Recent Advances in Molecular Targets for Treatment and Drug Delivery in Tumors

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: 28 February 2025 | Viewed by 21

Special Issue Editor


E-Mail Website
Guest Editor
Dipartimento di Scienze Mediche, Orali e Biotecnologiche, Center for Advanced Studies and Technology (CAST), University "G. d'Annunzio" di Chieti-Pescara, 66100 Chieti, Italy
Interests: targeted therapy; tumor biology; monoclonal antibody; antibody drug conjugate; extracellular vesicles
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cancer is a chronic disease representing about one-sixth of all global deaths, and to combat it, conventional therapeutic methods, including surgery, radiation therapy, and chemotherapy, have been applied in clinical practice. But it has been observed that these strategies do not effectively differentiate between pathological and normal cells, leading to several adverse effects; therefore, in recent decades, cytotoxic chemotherapy has given way to molecular-targeted drugs that are highly specific and have reduced toxicity. Recently, rapid progress in novel therapeutic strategies coupled with tumor-targeted candidates, containing neoantigens, hormonal agents, molecularly targeted agents, and immune checkpoint inhibitors, has offered new horizons for cancer-related molecular target discovery. Meanwhile, more applications in drug delivery systems have improved targeting, thus enhancing specific drug accumulation in tumor tissues.

We are pleased to invite you to contribute to our Special Issue of the International Journal of Molecular Sciences (IJMS), entitled “Recent Advances in Molecular Targets for Treatment and Drug Delivery in Tumors”, in order to collect recent advances in the field of molecular targeting, also bringing novel ideas to the scientific community.

This Special Issue aims to expanding current knowledge about the following topics:

  • The newly discovered molecular targets in tumors;
  • Recent advances in drug design based on molecular targets;
  • Recent advances in drug delivery strategies;
  • Molecular-targeted therapeutic strategies.

In this Special Issue, original research articles and reviews are welcome to be submitted. I look forward to receiving your contributions.

Dr. Emily Capone
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • targeted therapy
  • tumor
  • molecular target
  • drug delivery
  • drug design

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop